Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.6050
-0.8450 (-58.28%)
At close: Jun 5, 2025, 4:00 PM
0.6048
-0.0002 (-0.03%)
After-hours: Jun 5, 2025, 4:59 PM EDT

Cyclacel Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Cyclacel Pharmaceuticals.

Price Target: $0.00 (0.00%)
Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for Cyclacel Pharmaceuticals.

Recommendation Trends

Rating Dec '23Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy 111110
Buy 111110
Hold 111110
Sell 000000
Strong Sell 000000
Total 333330

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Roth MKM
Roth MKM
Strong Buy
Maintains
$336$176
Strong Buy Maintains $336$176 +28,990.91% May 3, 2024
Brookline Capital
Brookline Capital
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Dec 19, 2023
Roth MKM
Roth MKM
Strong Buy
Maintains
$256$336
Strong Buy Maintains $256$336 +55,437.19% Dec 19, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$1,920
Buy Maintains $1,920 +317,255.37% May 25, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$2,400$1,920
Buy Maintains $2,400$1,920 +317,255.37% Mar 7, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
102.00K
from 43.00K
Increased by 137.21%
Revenue Next Year
102.00K
from 102.00K
EPS This Year
-1.20
from -33.50
EPS Next Year
-1.14
from -1.20
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
---420.00K43.00K102.00K102.00K82.19M
Revenue Growth
-----89.76%137.21%-80,482.35%
EPS
-820.80-501.67-456.28-427.94-33.50-1.20-1.143.74
EPS Growth
--------
Forward PE
-------0.16
No. Analysts
-----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 105,000 105,000 84.6M
Avg 102,000 102,000 82.2M
Low 98,000 98,000 79.0M

Revenue Growth

Revenue Growth 202520262027
High
144.2%
2.9%
82,852.0%
Avg
137.2%
-
80,482.4%
Low
127.9%
-3.9%
77,321.6%

EPS Forecast

EPS 202520262027
High -1.24 -1.18 3.85
Avg -1.20 -1.14 3.74
Low -1.16 -1.10 3.60

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.